Relmada Therapeutics director buys $64,750 in company stock

Tomas Kauer - Moderator

Sep 12, 2024 - 06:00

Relmada Therapeutics director buys $64,750 in company stock

Tags:

Previous Article

Cyanotech executive Michael A. Davis buys shares worth $8,350

Humacyte CEO sells over $2.3 million in company stock

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Tomas Kauer - Moderator

Related Posts

South Korea market watchdog highlights pension fund's role in market reforms

South Korea market watchdog highlights pension fund's r...

Tomas Kauer - Mode... Sep 12, 2024

Orb founders grew so frustrated dealing with billing at Asana, they built their own billing software

Orb founders grew so frustrated dealing with billing at...

Tomas Kauer - Mode... Sep 17, 2024

Southwest Airlines Chairman Kelly to retire amid pressure from Elliott

Southwest Airlines Chairman Kelly to retire amid pressu...

Tomas Kauer - Mode... Sep 10, 2024